BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36485092)

  • 1. New developments in ALL in AYA.
    Boissel N
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):190-196. PubMed ID: 36485092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
    Grover P; Muffly L
    Curr Oncol Rep; 2022 Aug; 24(8):995-1001. PubMed ID: 35353349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment development for T cell acute lymphoblastic leukemia in children, adolescents, and young adults].
    Sato A
    Rinsho Ketsueki; 2022; 63(9):1325-1334. PubMed ID: 36198559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat acute lymphoblastic leukemia in older adolescents and young adults.
    Curran E; Stock W
    Blood; 2015 Jun; 125(24):3702-10. PubMed ID: 25805810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
    Testi AM; Canichella M; Vitale A; Piciocchi A; Guarini A; Starza ID; Cavalli M; De Propris MS; Messina M; Elia L; Moleti ML; Martino B; Luppi M; D'Aloisio M; Candoni A; Conter V; Fazi P; Vignetti M; Chiaretti S; Foà R
    Am J Hematol; 2021 Mar; 96(3):292-301. PubMed ID: 33284999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging health care technology to improve health outcomes and reduce outcome disparities in AYA leukemia.
    Molina JC; Rotz S
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):573-580. PubMed ID: 38066875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults].
    Yamazaki E
    Rinsho Ketsueki; 2022; 63(7):826-832. PubMed ID: 35922954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute lymphoblastic leukemia in adolescents and young adults].
    Hayakawa F
    Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adolescents and young adults with acute lymphoblastic leukemia. A specific management].
    Boissel N; Ducassou S
    Bull Cancer; 2017; 104(7-8):683-689. PubMed ID: 28576259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategy for treatment of acute lymphoblastic leukemia].
    Kobayashi Y
    Rinsho Ketsueki; 2018; 59(10):2019-2027. PubMed ID: 30305504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.
    Bourlon C; Lacayo-Leñero D; Inclán-Alarcón SI; Demichelis-Gómez R
    Curr Oncol Rep; 2018 Mar; 20(4):36. PubMed ID: 29577208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
    Mannis GN; Martin TG; Damon LE; Andreadis C; Olin RL; Kong KA; Faham M; Hwang J; Ai WZ; Gaensler KML; Sayre PH; Wolf JL; Logan AC
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1030-1036. PubMed ID: 26899561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.
    Orellana-Noia VM; Douvas MG
    Curr Hematol Malig Rep; 2018 Apr; 13(2):100-108. PubMed ID: 29442287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
    Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
    Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should we treat the AYA patient with newly diagnosed ALL?
    Boissel N
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):175-183. PubMed ID: 29050690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
    Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
    J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Minimal residual disease in adults with Philadelphia chromosome negative acute lymphoblastic leukemia in high-risk].
    Li ZR; Zhao T; Liu YR; Wang YZ; Xu LP; Zhang XH; Wang Y; Jiang H; Chen YY; Chen H; Han W; Yan CH; Wang J; Jia JS; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):554-560. PubMed ID: 32397017
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph-negative acute lymphoblastic leukemia.
    Nagafuji K; Miyamoto T; Eto T; Ogawa R; Okumura H; Takase K; Kawano N; Miyazaki Y; Fujisaki T; Wake A; Ohno Y; Kurokawa T; Kamimura T; Takamatsu Y; Yokota S; Akashi K
    Eur J Haematol; 2019 Sep; 103(3):164-171. PubMed ID: 31132205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
    Czyz A; Lewandowski K; Kroll R; Komarnicki M
    Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
    Burke MJ; Gossai N; Wagner JE; Smith AR; Bachanova V; Cao Q; MacMillan ML; Stefanski HS; Weisdorf DJ; Verneris MR
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):138-42. PubMed ID: 22960388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.